Consortium of Food Allergy Research Report issue

Academic/Hospital Phase 2
Founded: McLean Virginia United States (2005)

Organization Overview

First Clinical Trial
2007
NCT00461097
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

egg (2 trials)

peanut allergen (Palforzia) (3 trials)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Food Hypersensitivity (Phase 2)

Hypersensitivity (Phase 2)

Hypersensitivity, Immediate (Phase 2)

Peanut Hypersensitivity (Phase 2)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 3